Getinge awarded anaesthesia contract by U.S. healthcare improvement firm Leave a comment

Getinge has been awarded a new anaesthesia contract from Premier, Inc. a healthcare improvement company in the United States. The Flow Family’s technology provides personalised anaesthesia to cover the needs of all types of surgeries and patients.

Premier Inc. is a healthcare improvement company uniting approximately 4,400 U.S. hospitals and health systems and more than 225,000 other providers and organisations.

“Premier awarding Getinge this contract is an important milestone for our anaesthesia product line. This is the first time we are able to provide Premier members access to Flow Family Anaesthesia machines at a contract rate,” said Patricia Fitch, president, North America.

Getinge worked closely with clinicians to develop these anaesthesia machines designed to facilitate personalisation with patient safety in mind. With an intuitive interface, emphasis on ease of use, smart design, and a high level of automation, the Flow Family brings personalised anaesthesia delivery and smooth workflow to the operating room.

“Easier access to Flow Family Anaesthesia machines means that Premier members benefit from our innovative technology while providing personalised anaesthesia to all their patients, but especially to their most challenging patients, neonates and the morbidly obese,” added Fitch.

Every detail of the machines has been meticulously designed to help ensure optimal care with high efficiency. The Flow-e and Flow-c come equipped with the MAC Brain indicator. This technology visualises the difference in agent concentration between the lungs and target organ, the brain.

The reliability of the data places anaesthesiologists in control, allowing planning and delivery of more efficient agent dosing. All models in Getinge’s Flow Family include O2Guard, an active hypoxia prevention system. O2Guard automatically overrules the settings and increases the flow of oxygen if the inspired oxygen level drops below 21%, minimising the risk of hypoxia in challenging patient types.


Leave a Reply